paper
concern
studi
genom
wuhan
seafood
market
isol
believ
repres
caus
agent
diseas
find
short
section
section
viral
protein
sequenc
suitabl
preliminari
design
propos
peptid
synthet
vaccin
peptidomimet
therapeut
explor
design
possibl
project
origin
direct
toward
use
case
quel
languag
implement
knowledg
manag
autom
infer
system
medicin
call
bioingin
focu
remain
mostli
viru
howev
use
quel
system
access
relev
emerg
literatur
interact
standard
public
avail
bioinformat
tool
internet
help
quickli
identifi
sequenc
amino
acid
well
conserv
across
mani
coronavirus
includ
krsfiedllfnkv
found
particularli
well
conserv
studi
correspond
region
around
one
known
cleavag
site
sar
viru
believ
requir
viru
activ
cell
entri
sequenc
motif
surround
variat
form
basi
propos
specif
synthet
vaccin
epitop
peptidomimet
agent
work
nonetheless
describ
tradit
bioinformat
term
readili
reproduc
other
albeit
caveat
new
data
research
emerg
evolv
explos
pace
preliminari
studi
use
molecular
model
dock
context
potenti
valu
certain
known
herbal
extract
also
describ
coronavirus
virus
medic
veterinari
import
includ
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhea
viru
pedv
human
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
respons
epidem
middl
east
respiratori
syndrom
coronaviru
merscov
past
ten
year
mani
new
coronavirus
identifi
infect
wide
rang
host
mammal
bird
close
relat
coronavirus
identifi
distantli
relat
anim
suggest
recent
interspeci
jump
like
influenza
virus
similar
epidem
properti
singl
strand
rna
virus
lipoprotein
envelop
enter
host
cell
class
fusion
protein
ie
one
requir
viral
surfac
protein
fusion
viral
fusion
protein
potenti
therapeut
vaccin
target
indic
possibl
kind
consider
discuss
present
paper
extend
broader
rang
virus
present
seri
studi
eg
ref
concern
studi
genom
wuhan
seafood
market
isol
believ
respons
current
pandem
believ
viru
also
call
viru
diseas
design
nomenclatur
appar
still
fulli
settl
preced
choic
name
remain
popular
use
throughout
see
section
brief
account
concern
evolv
name
viru
concern
strain
far
matter
relat
find
regard
genom
design
synthet
vaccin
diagnost
peptidomimet
drug
concern
ref
may
regard
earli
preprint
present
paper
discuss
regard
particular
world
wide
web
access
methodolog
use
facilit
studi
see
section
viru
remain
prioriti
new
work
viru
includ
howev
although
absolut
essenti
use
robot
autobrows
surf
internet
captur
knowledg
keep
develop
prove
valuabl
case
situat
concern
import
scientif
data
chang
rapidli
one
may
expect
epidem
technic
pandem
least
tradit
criteria
concern
seemingli
previou
epidem
earli
stage
key
exampl
rapid
progress
timelin
particularli
relev
event
last
phase
studi
follow
paper
post
th
januari
first
version
present
paper
submit
journal
nd
februari
complet
studi
first
version
present
paper
bat
viru
ident
spike
protein
particular
interest
present
paper
describ
section
recent
bat
coronaviru
sequenc
enter
genbank
entri
addit
two
day
time
write
present
paper
th
februari
entri
doi
appear
protein
data
bank
pdb
three
dimension
structur
crystal
structur
main
proteas
encod
within
viral
genom
complex
inhibitor
may
expect
paper
consid
model
variou
viral
protein
interact
appear
almost
minut
use
autom
surf
method
describ
present
paper
exampl
appear
includ
lawrenc
livermor
nation
laboratori
announc
research
develop
preliminari
set
predict
protein
structur
aid
research
effort
combat
diseas
discuss
section
proteas
potenti
target
subject
interest
present
studi
time
studi
prepar
paper
unclear
perhap
even
discourag
viru
interest
consid
strain
sar
see
section
much
ref
earli
preprint
follow
notion
use
bat
particularli
human
sar
refer
model
ref
identifi
virus
close
relat
import
assumpt
molecular
mechan
infect
similar
seen
type
strain
sar
assumpt
seem
justifi
also
rather
trivial
howev
still
emphas
extent
cours
classif
nomenclatur
chang
molecular
relationship
sequenc
structur
describ
moreov
discuss
paper
virus
similar
help
design
mean
combat
viru
actual
weakli
match
genom
inform
kind
studi
might
describ
compar
bioinformat
inde
conserv
surfac
region
particular
interest
henc
emerg
viral
strain
nomenclatur
consid
incorrect
conclus
paper
like
one
would
like
remain
essenti
provid
still
sequenc
similar
surfac
protein
interest
continu
great
concern
due
high
rate
infect
protract
time
show
symptom
reason
analysi
done
way
relat
design
diagnost
vaccin
therapeut
agent
peptid
ie
molecul
compos
say
amino
acid
resid
relat
actual
part
amino
acid
sequenc
whole
viral
protein
see
section
section
continu
section
signific
limit
remedi
discuss
discuss
conclus
section
potenti
candid
segment
sequenc
converg
result
section
one
particularli
favor
section
sequenc
amino
acid
residu
modif
peptid
design
observ
regard
work
identifi
relat
smaller
rigid
compound
potenti
drug
also
discuss
along
preliminari
conform
dock
studi
despit
comment
remain
earli
stage
pandem
one
need
ensur
one
address
viru
describ
inde
cautiou
phrase
viru
might
mean
practic
regard
well
matter
literatur
search
help
neither
research
news
organ
meet
confer
organ
name
viru
diseas
constantli
chang
past
week
inde
day
decid
prefer
name
hour
releas
previou
report
present
author
januari
although
final
decis
viru
offici
name
still
await
intern
committe
taxonomi
virus
time
final
write
text
name
diseas
one
reason
speak
viru
previou
report
author
earli
point
wuhan
seafood
market
isol
viru
surfac
protein
particular
interest
close
relat
human
bat
sar
time
rewrit
present
paper
coronaviru
studi
group
csg
intern
committe
taxonomi
virus
decid
variant
coronaviru
caus
outbreak
sever
acut
respiratori
syndrom
sar
howev
new
name
univers
popular
nomenclatur
viru
use
throughout
text
chines
research
govern
work
industri
publish
determin
earli
detect
wuhan
viru
sever
web
site
time
write
concern
express
often
outsid
mainstream
peer
review
scientif
literatur
seen
current
pandem
due
viru
specifi
wuhan
seafood
market
pneumonia
viru
isol
eg
ref
ie
genbank
entri
use
januari
replac
probabl
repres
adequ
stabl
descript
sequenc
research
strain
isol
entri
describ
rna
viru
rna
sequenc
base
despit
concern
believ
avail
time
present
studi
essenti
wuhan
seafood
market
isol
except
genom
chang
due
accept
mutat
typic
case
cours
viral
epidem
rna
virus
usual
held
much
higher
mutat
rate
dna
virus
consider
impact
central
theme
paper
part
surfac
viru
normal
interact
host
cell
entri
vulner
host
immun
system
unfortun
also
expos
region
surfac
protein
accept
mutat
readili
except
import
interact
site
compound
design
weapon
viru
base
section
amino
acid
sequenc
readili
chang
quickli
becom
useless
escap
mutat
strain
thu
import
note
less
variat
viru
genom
take
account
relationship
genom
interest
close
relat
distantli
relat
virus
particularli
inform
present
kind
studi
also
import
direct
inform
structur
function
action
protein
encod
genom
time
write
avail
one
seek
make
reason
extrapol
known
relat
virus
specif
focu
class
fusion
protein
coronavirus
glycoprotein
known
spike
protein
protrud
extens
viru
envelop
surfac
respons
bind
receptor
host
cell
well
mediat
fusion
host
viral
membran
frequent
refer
spike
protein
spike
glycoprotein
synthes
singlechain
precursor
approxim
amino
acid
form
trimer
protein
fold
trimer
sar
coronaviru
sarscov
spike
glycoprotein
consist
three
heterodim
bind
cellular
receptor
angiotensinconvert
enzym
mediat
fusion
viral
cellular
membran
preto
postfus
conform
transit
airway
proteas
cleavag
site
along
amino
acid
sequenc
sarscov
glycoprotein
identifi
read
nterminu
import
function
element
spike
includ
proteas
cleavag
site
describ
sar
studi
ntermin
domain
ctermin
domain
first
proteas
cleavag
site
loop
pleat
sheet
ahelix
fusion
peptid
fp
associ
highli
disord
loop
two
ahelic
contain
second
cleavag
site
heptad
repeat
hr
fig
show
approxim
posit
cleavag
point
sar
spike
protein
within
trimer
superimpos
protein
data
bank
entri
heptad
repeat
far
attract
interest
research
lead
therapeut
prevent
agent
membran
fusion
cell
entri
mediat
extens
postreceptorbind
structur
rearrang
two
heptad
repeat
hr
region
play
key
role
posit
ctermin
hydrophob
fusion
peptid
locat
ntermin
transmembran
domain
central
fusion
process
format
stabl
sixhelix
bundl
region
assembl
groov
form
trimer
coil
coil
care
need
deduc
mechan
activ
cell
entri
henc
potenti
therapi
basi
use
differ
type
viru
refer
model
four
main
type
coronaviru
differ
spike
protein
known
differ
activ
lung
cell
entri
renam
believ
caus
agent
indic
type
sar
allevi
concern
differ
strain
use
differ
mechan
point
mutat
might
chang
mode
cell
entri
entri
type
repres
exampl
follow
genu
alphacoronaviru
human
coronaviru
porcin
transmiss
gastroenter
coronaviru
tgev
porcin
epidem
diarrhea
coronaviru
pedv
porcin
respiratori
coronaviru
prcv
genu
betacoronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
bat
coronaviru
mous
hepat
coronaviru
mhv
bovin
coronaviru
bcov
human
coronaviru
genu
gammacoronaviru
avian
infecti
bronchiti
coronaviru
ibv
genu
deltacoronaviru
porcin
deltacoronaviru
pdcv
bioinformaticsbas
approach
also
reproduc
standard
tool
facilit
quel
tool
especi
explos
growth
studi
regard
alphacoronaviru
betacoronaviru
sarscov
recogn
zinc
peptidas
angiotensinconvert
enzym
target
cell
bind
alphacoronavirus
tgev
pedv
prcv
recogn
zinc
peptidas
call
aminopeptidas
n
apn
also
exampl
sarscov
betacoronavirus
recogn
differ
receptor
merscov
recogn
serin
peptidas
dipeptidyl
peptidas
known
studi
sar
coronaviru
activ
trypsinlik
proteas
natur
present
lung
appear
essenti
activ
viru
cell
bind
entri
cleav
two
site
three
dimension
structur
origin
human
sar
spike
protein
known
high
resolut
electron
microscopi
though
point
mutat
might
chang
entri
mechan
achil
heel
coronaviru
resid
certain
part
spike
protein
discuss
natur
choic
preliminari
weapon
synthet
peptid
eg
ref
choic
reflect
histori
synthet
otherwis
biotechnolog
produc
peptid
develop
rapidli
sinc
seen
basi
therapeut
vaccin
relat
work
research
exemplifi
ref
effort
cite
appropri
point
regard
pathogen
gener
section
like
mani
effort
author
colleagu
also
signific
success
past
design
synthet
peptid
least
use
way
help
combat
diseas
epidem
includ
report
studi
includ
hiv
prove
diagnost
valu
laboratori
eg
ref
bse
bovin
spongiform
encephalopathi
mad
cow
diseas
led
earli
use
diagnost
market
worldwid
abbott
laboratori
exampl
studi
includ
immunotherapeut
strategi
put
vaccin
bacteri
pathogen
ebola
flavivirus
see
ref
discuss
gener
introductori
review
kind
approach
project
result
bodi
experi
design
rulesofthumb
author
collabor
seek
captur
method
describ
section
understood
peptid
propos
bepitop
construct
synthet
peptid
rare
work
well
alon
recal
immunogen
abil
particular
substanc
provok
immun
respons
bodi
epitop
antigen
determin
small
part
antigen
recogn
distinguish
immun
system
specif
antibodi
b
cell
cell
ensur
choic
segment
sequenc
synthesi
presenc
amino
acid
least
reason
level
immunogen
small
import
first
step
vaccin
construct
none
studi
present
author
collabor
previous
address
coronaviru
signific
way
sever
laboratori
skill
coronaviru
scienc
use
peptid
base
heptad
repeat
hr
consid
antivir
drug
prohibit
viru
cell
entri
signific
success
laboratori
coronavirus
host
speci
eg
ref
howev
author
knowledg
signific
success
toward
medic
product
base
hr
one
reason
may
coronavirus
escap
peptid
entri
inhibit
mutat
particularli
indic
domain
spike
fusion
protein
suggest
limit
option
exist
escap
inhibitori
effect
peptid
altern
two
cleavag
site
requir
activ
cell
entri
sinc
site
expos
solvent
plausibl
target
sever
prevent
therapeut
diagnost
purpos
site
may
also
repres
epitop
serv
either
basi
design
synthet
peptid
vaccin
link
carrier
protein
deign
clone
protein
even
fail
implant
immun
memori
may
also
form
basi
product
antibodi
sera
passiv
immun
usein
diagnost
kit
biosensor
importantli
also
possibl
case
peptid
analogu
heptad
repeat
might
serv
basi
design
inhibitor
cell
entri
bind
coronaviru
trypsinlik
proteas
lung
prevent
manner
prior
viru
exposur
earli
peptid
studi
author
colleagu
discov
bioinformat
peptid
protein
model
step
requir
investig
capabl
high
degre
autom
prometheu
expert
system
base
global
polymorph
program
languag
also
develop
author
colleagu
play
major
role
mani
later
peptid
studi
includ
bse
diagnost
gener
idea
user
perspect
use
present
studi
employ
recent
quel
languag
languag
significantli
differ
global
languag
radic
extens
xml
probabilist
semant
tag
algebra
forc
alreadi
seen
provid
use
platform
studi
epidem
design
peptid
theori
behind
quel
describ
develop
sever
essenti
mathemat
paper
ref
provid
relev
appli
mathemat
account
conjunct
algorithm
softwar
develop
ref
provid
first
detail
descript
quel
languag
mean
interact
world
wide
web
potenti
prove
basi
think
web
medicin
primarili
render
emerg
semant
web
fundament
probabilist
underli
theori
probabilist
semant
somewhat
irrelev
present
case
great
need
consid
probabl
associ
element
knowledg
bioinformat
coronavirus
quel
xmllike
tag
express
note
howev
probabl
becom
relev
clinic
genom
involv
patient
dna
sequenc
similar
case
made
homolog
extent
match
viral
protein
sequenc
use
autom
probabilist
reason
use
futur
quel
part
concern
autom
comput
internetcentr
research
task
mainli
present
studi
involv
automat
surf
world
wide
web
speed
access
inform
coronavirus
captur
canon
form
ie
que
xmllike
tag
statement
knowledg
major
brief
summari
previou
work
current
convent
think
peptid
seen
epitop
gener
envisag
need
attach
immunogen
protein
safe
patent
receiv
test
organ
familiar
receiv
immun
system
caus
signific
cross
reaction
eg
induc
autoimmun
diseas
also
b
epitop
expos
region
pathogen
key
antibodi
respons
epitop
anywher
pathogen
protein
may
need
tsystem
memori
cellular
respons
overal
structur
may
benefit
linkag
molecular
adjuv
muramyl
dipeptid
possibl
stimul
antisuppressor
peptid
short
peptid
initi
interest
may
small
part
would
look
like
complex
molecular
swiss
armi
knife
nonetheless
addit
vari
extent
alreadi
understood
support
technolog
even
yet
favor
human
usese
discuss
later
variou
compon
seen
interchang
andor
reusabl
part
essenc
cartridg
approach
synthet
vaccin
intend
facilit
quicker
respons
new
infecti
diseas
among
bepitop
part
viru
surfac
remain
key
immun
system
recognit
differ
previou
genom
use
case
quel
notion
type
coronaviru
strain
replac
notion
human
patient
specif
softwar
decis
support
system
interact
internet
recent
bioingin
implement
quel
associ
softwar
applic
applic
gener
use
quel
tag
extract
commun
knowledg
draw
conclus
autom
infer
interact
sourc
text
bioinformat
tool
world
wide
web
keep
origin
intend
spirit
facilit
think
web
internet
howev
quel
tag
serv
role
architectur
principl
see
fig
bioinformat
base
approach
right
hand
side
fig
could
carri
usual
way
interact
manual
web
site
sometim
quel
role
facilit
essenti
studi
except
sens
paper
may
arguabl
may
written
differ
much
later
face
explos
develop
worldwid
research
one
sever
motiv
develop
integr
genom
bioinformat
approach
base
quel
popular
highli
integr
biolog
workbench
san
diego
supercomput
center
longer
avail
time
write
howev
standard
web
tool
use
promin
present
work
coronaviru
spike
sequenc
alreadi
suit
least
integr
aspect
concern
particular
tool
web
page
suffici
easi
use
normal
manual
way
nonetheless
autom
approach
valuabl
speedier
research
captur
knowledg
internet
quel
tag
well
captur
expertis
human
user
regard
workflow
lead
full
reproduc
part
output
blastp
use
http
blastncbinlmnihgovbla
stcgi
still
express
form
familiar
bioinformat
research
rather
appear
quel
tag
also
see
ref
format
quel
represent
bioinformat
inform
kind
previous
number
way
gather
inform
internet
quel
tag
form
explor
exampl
quelctract
tag
ref
gener
interact
html
webpag
googl
queri
result
list
hit
present
paper
extens
use
made
marplehdnstud
xtractor
provid
conveni
way
make
search
queri
initi
autosurf
internet
present
case
quel
tag
alreadi
repres
statement
medic
knowledg
kr
albeit
sever
tag
found
essenti
duplic
knowledg
howev
yet
exhaust
medic
knowledg
focus
number
special
medic
area
mani
relat
viral
infect
detail
time
studi
regard
structur
henc
gather
new
knowledg
internet
import
cours
recent
phase
studi
site
particularli
frequent
hit
http
enwikipediaorgwikinovelcoronaviru
content
chang
significantli
sinc
first
appear
remain
good
secondari
scientif
news
sourc
concern
cours
epidem
wikipedia
entri
appear
regularli
updat
tabl
show
one
letter
amino
acid
code
use
peptid
protein
primari
structur
throughout
studi
follow
text
also
show
consensu
conserv
substitut
cours
evolut
accept
mutat
common
secondari
structur
propens
altern
peptid
design
ie
amino
acid
residu
similar
properti
focu
design
relationship
intend
symmetr
eg
start
e
give
one
option
go
e
actual
choic
simul
studi
chang
depend
detail
interact
xtractor
access
sever
way
one
gener
tag
follow
describ
lawrenc
livermor
nation
laboratori
llnl
research
develop
preliminari
set
predict
protein
structur
viru
aid
research
effort
combat
diseas
follow
exampl
new
tag
specif
develop
present
project
note
queri
protein
structur
predict
coronaviru
word
also
legal
nomin
categor
data
type
legal
attribut
tag
construct
anoth
exampl
statu
report
follow
one
letter
amino
acid
code
use
text
amino
acid
conserv
replac
contrast
xtractor
use
marpl
big
advantag
captur
pars
standard
content
present
case
essenti
repurpos
number
examinationlik
question
set
question
replac
brief
project
descript
answer
replac
queri
eg
case
investig
wuhan
seafood
market
coronaviru
bioinformat
analysi
spike
protein
answer
wuhan
coronaviru
b
sar
c
coronavirus
spike
protein
e
lung
diseas
final
weight
candid
answer
similar
case
rest
simpli
suggest
process
reason
found
queri
highli
relev
question
part
process
score
world
wide
web
answer
queri
text
captur
pars
reorgan
xtract
tag
futur
use
autom
infer
readili
decompos
semant
tripl
linear
semant
multipl
howev
present
project
primarili
valu
collect
knowledg
review
research
part
autom
systemat
review
process
time
stamp
tag
along
proven
inform
use
research
even
site
chang
exampl
follow
note
contract
basic
relationship
repars
annot
canon
form
make
use
easi
comput
sometim
give
rather
stilt
bad
english
present
automat
extract
relev
text
prior
process
refer
also
access
easi
human
read
follow
show
amino
acid
sequenc
standard
iupac
one
letter
code
see
tabl
spike
glycoprotein
deduc
wuhan
seafood
market
pneumonia
viru
isol
complet
genom
genbank
technic
speak
exist
natur
spike
glycoprotein
theoret
comput
translat
predict
orf
open
read
frame
far
known
author
present
time
howev
comparison
sar
would
make
altern
interpret
unlik
even
prior
recent
name
sar
type
recent
close
match
sar
viru
entri
databas
make
assumpt
use
present
paper
much
plausibl
howev
describ
ref
quel
tag
obtain
orf
open
read
frame
genbank
slightli
differ
ref
specif
suit
human
mitochondri
genom
similar
tag
also
carri
secondari
structur
predict
usual
term
h
e
extend
chain
sheet
c
coil
loop
conform
state
amino
acid
residu
tag
along
quelorfaaconsensussequ
tag
help
ratifi
translat
plausibl
real
one
give
insight
structur
function
consensu
tag
show
sequenc
amino
acid
residu
translat
orf
usual
associ
posttransl
modif
bind
catalyt
site
etc
exampl
put
protein
occurr
n
asparagin
follow
residu
p
prolin
follow
turn
serin
threonin
glycosyl
like
occur
follow
residu
p
prolin
typic
extracellular
protein
secondari
structur
predict
extract
shown
along
known
cleavag
site
sar
spike
protein
shown
short
section
sar
sequenc
cleavag
occur
arginin
r
cut
occur
indic
charact
underneath
shown
string
charact
h
e
c
secondari
structur
predict
use
gor
method
version
iv
avail
rhonealp
protein
institut
biolog
chemistri
websit
quel
tag
yet
combin
cleavag
site
sequenc
larger
amino
acid
sequenc
although
align
tag
similar
blast
result
tag
use
play
similar
role
cleavag
site
rule
proteas
includ
dictionari
consensu
sequenc
would
least
show
amino
acid
residu
point
cut
eg
k
lysin
r
arginin
case
trypsin
immedi
vicin
purpos
predict
secondari
structur
context
fold
protein
structur
nativ
conform
known
experiment
sar
like
similar
glycoprotein
inde
secondari
structur
could
ultim
deduc
way
fairli
high
resolut
eg
term
dihedr
angl
express
term
x
rang
eg
although
doubtless
ultim
found
signific
differ
sar
level
resolut
especi
consid
differ
sequenc
signific
rather
purpos
otherwis
twofold
first
purpos
simpli
base
empir
find
author
residu
predict
coil
loop
c
tend
form
good
basi
peptid
chosen
design
diagnost
vaccin
see
discuss
later
irrespect
whether
predict
correct
irrespect
rule
waterlik
charact
exposur
intrins
immunogen
discuss
later
albeit
natur
overlap
second
give
peptid
design
idea
like
popul
conform
residu
h
e
c
detail
kind
predict
type
helix
sheet
turn
bend
latter
regard
conform
behavior
peptid
copi
model
local
region
sequenc
amino
acid
residu
length
less
synthes
peptid
like
exist
solut
open
dynam
random
configur
may
envisag
statist
mechan
averag
mani
overal
conform
similar
energi
correspond
predict
predict
use
deliber
includ
strong
influenc
perturb
intrins
prefer
residu
conform
occur
amino
acid
residu
must
fit
rest
fold
structur
ie
socal
tertiari
interact
gor
method
predict
also
make
use
align
sequenc
mani
homolog
protein
use
deliber
design
influenc
conform
prefer
residu
compact
fold
motif
similarli
intrins
quel
learn
approach
appli
predict
secondari
structur
use
fig
paper
illustr
point
show
circa
arbitrarili
select
protein
brought
train
set
predict
begin
chang
improv
dramat
homolog
protein
similar
fold
structur
encount
coverag
sampl
protein
span
common
protein
famili
obviou
preknown
homologu
discard
studi
concern
still
appli
two
site
promin
alon
amongst
cleavag
point
research
discov
sar
spike
protein
marpl
xtractor
abl
extract
world
wide
web
number
sequenc
cleav
variou
proteas
includ
ref
ref
also
note
potenti
site
trypsin
plasmin
transmembran
proteas
other
extract
websit
includ
also
follow
gener
sequenc
region
lkptkrsfiedllfnkvtladagfmk
alreadi
look
particular
interest
varieti
protein
cleav
within
region
potenti
activ
viru
cell
entri
includ
trypsin
elastas
plasmin
divers
type
proteas
present
human
lung
includ
variou
serin
cysteinyl
aspartyl
metalloproteas
part
function
extracellularli
well
intracellularli
perform
varieti
normal
function
neutrophil
chemotaxi
tissu
remodel
mucin
express
least
viral
bacteri
destruct
function
could
priori
involv
coronaviru
spike
activ
protein
albeit
like
differ
extent
howev
region
mean
region
proteolysi
could
occur
exemplifi
closest
homolog
sequenc
match
whole
sequenc
entri
spike
protein
bat
sarslik
coronaviru
sequenc
id
genbank
entri
coverag
sequenc
name
entri
match
close
top
match
bat
host
speci
three
match
note
earli
studi
list
match
recent
reason
unclear
remain
close
match
sequenc
top
coverag
match
rang
howev
somewhat
decept
exampl
search
specif
spike
glycoprotein
sequenc
relat
host
pig
su
scrofa
one
obtain
varieti
match
circa
homolog
coverag
typic
regard
weak
common
rule
thumb
ident
entir
length
requir
signific
higher
ident
seen
chanc
short
align
howev
infrequ
case
homolog
studi
assumpt
meaning
homolog
align
strengthen
known
common
function
suspect
common
ancestri
protein
persuas
match
section
often
known
function
signific
might
expect
consider
search
whole
sequenc
two
section
around
two
arginin
cleavag
site
reveal
broader
varieti
coronavirus
host
speci
human
bat
pig
civet
group
speci
rel
close
set
match
region
site
interest
illustr
kind
accept
mutat
synthet
peptid
substitut
singl
amino
acid
residu
occur
near
cleavag
point
ie
kind
variat
altern
may
interest
peptid
design
unclutt
mani
variat
human
bat
pig
civet
host
speci
encount
search
pigag
contain
motif
sequenc
call
pigag
short
match
coronaviru
isol
human
bat
pig
civet
arbitrari
exampl
select
show
pattern
variat
follow
summari
align
made
discuss
section
show
signific
variat
case
pig
becom
plgdg
motif
essenti
sequenc
featur
cleav
arginin
r
still
retain
fiedll
contain
motif
sequenc
call
fiedll
short
also
match
coronaviru
isol
human
bat
pig
exampl
follow
show
signific
variat
case
pig
krsfiedll
sequenc
highli
conserv
henc
cleav
arginin
r
still
retain
note
section
krsfiedllfnkv
highli
conserv
overal
apart
tyrosin
replac
second
phenylalanin
f
one
case
pattern
seen
broader
set
align
isol
coronaviru
pig
notabl
distinct
relat
group
vlgvsvydpasgrvvq
fnkvvtnglgtvdedykrc
around
bound
krsfiedll
suffici
marker
close
match
identifi
pig
diarrhea
epidem
coronavirus
amongst
spike
glycoprotein
sequenc
examin
nvl
common
triplet
occur
triplet
often
occur
twice
mani
spike
glycoprotein
eg
bat
also
fiedll
motif
unless
shortli
preced
fiedll
motif
nvlgvsvydpa
grvvqkrsfiedllnkvvt
pig
epi
diarrhea
v
id
intern
match
fiedll
motif
signific
nvl
follow
sequenc
usual
carri
cleavag
arginin
r
correspond
point
varieti
standard
bioinformat
format
explor
quel
attribut
express
align
biosequ
final
settl
userselect
option
popular
author
collabor
movabl
attribut
mean
option
appear
mani
kind
tag
genom
sequenc
usual
compar
univers
agre
refer
standard
order
help
origin
align
detect
possibl
error
highlight
variat
present
studi
often
appear
quelorf
protein
tag
concern
orf
spike
protein
coronaviru
sequenc
analog
refer
sequenc
ref
evid
choic
tag
vehicl
somewhat
arbitrari
refer
standard
appropri
specif
viru
project
present
kind
also
use
blastp
domin
present
project
contrast
previou
genom
studi
also
made
extens
use
align
technolog
relat
clustalw
pairwis
align
alreadi
natur
gener
blastp
format
use
compris
use
blank
nonmatch
plu
conserv
differ
ie
amino
acid
match
ident
similar
type
amino
acid
default
notion
similar
howev
tabl
exampl
attribut
concern
section
sequenc
follow
see
ref
extens
span
whole
gene
protein
howev
match
report
familiar
output
blastp
actual
appear
http
blastncbinlmnihgovblast
cgi
queri
usual
protein
note
top
subjct
one
protein
found
match
note
bottom
note
search
specif
spike
glycoprotein
sequenc
relat
host
pig
su
scrofa
one
obtain
mani
match
circa
homolog
coverag
weak
persuas
match
section
interest
point
allud
socal
fiedll
motif
clearli
evid
retain
cleavag
arginin
r
though
pigag
motif
essenti
miss
correctli
mean
highli
modifi
cleavag
arginin
r
miss
align
region
two
cleavag
site
follow
extent
cleavag
segment
mostli
discuss
underlin
queri
indic
sequenc
sbjct
pig
viru
sequenc
genbank
also
typic
larg
number
pig
diarrhea
coronavirus
differ
one
two
amino
acid
residu
differ
spike
protein
align
well
particularli
ntermin
side
fiedl
motif
compar
exampl
variat
pigag
region
glycoprotein
sar
coronaviru
id
respect
spike
glycoprotein
signific
variat
vicin
pigag
motif
preserv
cleavag
arginin
found
similarli
glycoprotein
sequenc
id
consequ
loss
pigag
site
cleavag
arginin
case
focu
section
dpskpskrsfiedllfnkv
arginin
constitut
cleavag
point
underlin
pigag
site
would
suitabl
design
base
assumpt
bind
proteas
gener
would
seem
promis
increas
abil
viru
escap
mutat
success
vaccin
therapeut
base
region
admittedli
vicin
fiedll
site
show
great
variat
krsfiedllfnkv
tend
well
preserv
eg
align
pig
protein
id
peptid
mimic
part
protein
protein
sequenc
term
amino
acid
sequenc
intent
biolog
function
inhibitor
often
refer
peptidomimet
author
use
term
specif
analogu
depend
immun
respons
act
antagonist
case
bind
cleavag
point
synthesi
peptid
plausibl
analogu
immunogen
part
epitop
protein
develop
diagnost
peptid
interest
rational
section
krsfiedllfnkv
expos
associ
surfac
highli
conserv
shown
second
ie
fiedll
align
section
bring
length
circa
amino
acid
residu
consid
author
experi
frequent
worker
suitabl
basi
bepitop
vaccin
diagnost
design
note
preced
serin
follow
leucin
l
alanin
found
well
conserv
human
host
bat
host
speci
repres
fairli
conserv
substitut
next
relat
coronavirus
pig
host
speci
remain
principl
use
design
summar
end
section
alongsid
similar
discuss
peptidomimet
method
design
typic
epitop
synthet
peptid
vaccin
base
rulesofthumb
discuss
section
similar
two
case
choic
support
fact
correspond
expos
loop
sar
coronaviru
import
rais
antibodi
end
peptid
amino
carboxyl
group
shown
link
rest
protein
sequenc
neutral
peptid
link
end
peptid
thu
select
rational
expos
ntermin
nh
glycin
g
mimic
albeit
imperfectli
posit
charg
lysin
k
kp
triplet
b
cystein
coo
provid
mean
cysssci
disulfid
link
carrier
protein
expos
carboxi
terminu
mimic
albeit
imperfectli
aspart
lad
triplet
carrier
protein
requir
ad
antibodi
product
tsystem
memori
short
peptid
limit
antigen
keyhol
limpet
haemocyanin
often
use
least
rais
antibodi
earli
stage
vaccin
studi
use
laboratori
anim
deriv
limpet
gastropod
phylogenet
distant
mammalian
protein
thu
reduc
fals
posit
immunologicallybas
research
techniqu
mammalian
model
organ
clinic
avoid
autoimmun
effect
convent
wisdom
select
amino
acid
residu
synthes
peptid
use
basi
diagnost
vaccin
follow
concern
rais
antibodi
b
immun
system
implant
immun
system
memori
case
vaccin
specif
avoid
unwant
cross
reaction
protein
similar
epitop
target
protein
interest
peptid
length
gener
best
amino
acid
mani
significantli
polar
hydrophil
waterlik
residu
set
stdenqkrhyp
length
thu
consid
appropri
amino
acid
residu
tackl
issu
avoid
potenti
immunolog
crossreact
human
protein
closest
match
appropri
correspond
nontermin
sequenc
kgpskrsfiedllfnkvtlacd
human
genom
protein
product
genbank
follow
match
ident
coverag
tumor
protein
isoform
homo
sapien
id
similarli
tumor
protein
homo
sapien
id
next
match
regard
neprilsyn
entri
match
coverag
match
unlik
concern
convent
wisdom
design
peptid
basi
diagnost
vaccin
also
one
avoid
pair
triplet
etc
prolin
p
serin
rg
pair
common
motif
special
function
role
pair
ps
candid
peptid
doublet
concern
author
experi
asparagin
n
serin
threonin
avoid
pattern
nx
nxt
x
prolin
like
glycosyl
extracellular
protein
unless
design
go
arrang
glycosyl
synthet
peptid
issu
signific
coronaviru
match
cystein
c
avoid
perhap
replac
serin
least
format
unwant
cysci
ss
disulfid
bond
although
either
end
peptid
cy
c
alreadi
present
ad
provid
link
carrier
protein
essenti
b
immun
system
antibodi
respons
system
memori
gener
informationrich
content
bind
term
polar
nonpolar
hydrophob
water
hate
matter
convent
wisdom
also
say
avoid
extens
stretch
strongli
nonpolar
amino
acid
residu
vlifw
although
extens
hydrophob
also
consid
characterist
featur
immunogen
mhc
class
cell
epitop
epitop
play
dual
b
epitop
role
pattern
hydrophob
residu
interspers
hydrophil
residu
consid
mani
essenti
immunogen
author
experi
residu
sidechain
partli
polar
partli
nonpolar
notabl
tyrosin
histidin
h
seem
particularli
help
term
immunogen
research
also
sometim
avoid
ntermin
asparagin
n
glutamin
q
ctermin
prolin
p
glycin
g
consid
issu
regard
immunogen
purpos
candid
simpl
rulesofthumb
design
peptid
part
certainli
autom
base
appropri
section
section
sequenc
protein
pathogen
one
wish
attack
variat
strongli
weakli
relat
virus
take
less
consider
human
host
protein
cleav
proteolysi
bind
howev
knowledg
human
protein
involv
would
certainli
use
featur
design
least
one
might
use
experiment
comput
model
one
might
expect
amino
acid
sequenc
peptid
protein
substrat
cleav
airway
proteas
relat
cleav
glycoprotein
unfortun
obvious
appar
sequenc
level
discuss
section
type
ii
transmembran
serin
proteas
like
target
cleavag
activ
base
studi
sarscov
still
requir
clarif
natur
sequenc
typic
cleav
discuss
section
relat
krsfiedllfnkv
model
substrat
sequenc
type
ii
transmembran
serin
proteas
aeaalrklleva
probabl
signific
trypsin
cleav
peptid
ctermin
side
lysin
k
arginin
r
amino
acid
residu
prolin
residu
p
either
side
cleavag
imped
zincbas
angiotensin
convert
enzym
ace
cleav
cleavag
site
lf
hrk
l
vertic
bar
separ
altern
convert
angiotensin
drvyihpfhl
angiotensin
ii
drvyihpf
certain
suggest
stretch
sequenc
coronavirus
weakli
resembl
angiotensin
eg
rvvhpalhl
atyyhpnirvgvfhd
none
correspond
lie
near
trypsin
cleavag
point
sar
glycoprotein
best
imagin
match
segment
dpskpskrsfiedll
though
dp
aspartateprolin
suggest
featur
ace
inhibitor
obviou
relat
protein
cleavag
site
angiotensinogen
major
difficulti
peptid
pharmaceut
agent
lack
biostabl
readili
cleav
proteas
part
protect
dispos
mechan
bodi
albeit
one
use
advantag
coronavirus
also
suscept
partial
proteolysi
larg
enough
bind
endogen
protein
caus
unwant
immun
effect
judici
use
dextro
amino
acid
mirror
imag
natur
l
laevo
counterpart
enhanc
biostabl
recogn
common
proteas
bodi
consequ
peptid
contain
degrad
easili
longerlast
effect
vaccin
inhibitor
drug
insert
damino
acid
amongst
mani
lamino
acid
residu
requir
difficult
design
much
trial
error
although
except
ctermin
conjug
damino
acid
glycosid
lpeptid
usual
provid
simpl
way
gain
longterm
biostabl
rel
simplic
theoret
basi
retroinverso
approach
regain
popular
retroinverso
analog
natur
polypeptid
entir
compos
damino
acid
sometim
mimic
structur
function
natur
peptid
analogu
peptid
sequenc
revers
direct
respect
natur
peptid
also
chiral
amino
acid
invert
l
word
sequenc
synthes
backward
last
residu
first
amino
acid
use
instead
l
overal
effect
leav
sidechain
origin
side
peptid
backbon
one
disadvantag
amid
nh
carbonyl
c
group
interchang
backbon
problem
probabl
much
differ
conform
achiev
gener
sinc
sidechain
potenti
correctli
place
induct
interact
receiv
protein
bind
site
present
case
lung
proteas
surfac
loop
origin
protein
present
case
spike
glycoprotein
rather
one
c
ie
amid
group
hydrogen
bond
form
backbon
loop
origin
protein
bind
site
unstabl
c
c
interact
unless
accommod
correctli
conform
chang
interven
water
latter
unreason
sinc
simul
peptid
water
shown
one
two
water
molecul
often
interven
even
correctli
pair
nh
c
group
manner
c
typic
point
water
hydrogen
atom
oxygen
lone
pair
electron
cloud
posit
would
occur
repres
easi
handl
problem
termin
amino
nh
carboxyl
coo
group
also
interchang
well
retroinverso
modif
sequenc
accommod
termini
consequ
origin
sequenc
replac
one
emul
lysin
k
new
nterminu
aspart
cterminu
neither
first
lpeptid
follow
dpeptid
correspond
simpli
peptid
would
synthes
origin
well
conserv
krsfiedllfnkv
sequenc
step
defin
detail
sequenc
drawn
person
experi
common
known
practic
variou
publish
sourc
eg
ref
experiment
studi
bind
cleavag
studi
specif
sarscov
relev
system
eg
ref
relat
sarscov
studi
smaller
ligand
eg
ref
discuss
later
gener
studi
ligand
bind
protein
hydrophob
group
hydrogen
bond
group
remov
insert
eg
ref
fortun
least
captur
expertis
autom
interest
possibl
write
core
set
rule
endur
explain
choic
peptid
section
sequenc
interest
determin
bioinformat
method
rule
innat
logic
extens
studi
gener
kind
one
debat
except
seen
seen
origin
propos
retroinverso
peptid
prolin
p
substitut
arginin
r
end
section
rkspc
retroinverso
peptidomimet
shown
discuss
discuss
conclus
section
primari
rule
thumb
use
follow
first
recal
sequenc
wuhan
seafood
market
isol
region
follow
fig
emodin
found
elsewher
inhibitor
sarscov
entri
bind
featur
involv
keton
group
akin
carbenoxelon
number
molecul
may
consid
substructur
carbenoxelon
steroidlik
ring
compar
altern
part
bracket
rrsfidelafgrg
exampl
tent
specif
design
hunch
base
section
human
semaphorin
genbank
produc
respons
lung
diseas
suggest
biologicallyrel
match
conserv
replac
one
suggest
gener
rule
probabl
coincident
first
peptid
suitabl
candid
peptid
vaccin
principl
given
core
krsfiedllfnkv
sequenc
motif
follow
add
ctermin
cystein
c
linkag
chemic
linkag
certainli
possibl
carrier
connect
moder
flexibl
tla
threonineleucinealanin
arm
found
locu
conserv
retain
coronavirus
sequenc
specif
la
coo
terminu
protein
mimic
aspart
found
posit
origin
sequenc
accordingli
peptid
model
epitop
cterminu
also
similar
cystin
ss
bridg
residu
found
right
ctermin
side
section
natur
sequenc
albeit
probabl
signific
consider
natur
occur
c
residu
way
similarli
nterminu
truncat
immedi
follow
lysin
k
amino
termin
nh
mimic
howev
glycin
g
includ
give
flexibl
length
consist
mimick
lysin
sidechain
retroinverso
mimet
write
sequenc
backward
think
term
damino
acid
use
end
charg
charg
sidechain
mimic
revers
correctli
state
role
posit
neg
charg
sidechain
use
switch
c
termin
linker
site
aspart
coo
termin
mimic
end
toward
nterminu
sequenc
truncat
charg
nterminu
mimic
lysin
k
glycin
insert
give
appropri
flexibl
length
lysin
sidechain
better
mimick
simul
molecular
model
studi
potenti
agonist
go
beyond
rulesofthumb
clearli
benefit
knowledg
three
dimension
structur
atom
detail
protein
interact
automat
vigil
method
author
collabor
inde
standard
use
internet
author
fail
respect
need
improv
situat
appear
time
major
simul
studi
project
delay
experiment
structur
spike
protein
forthcom
current
rate
research
doubtless
soon
experiment
three
dimension
structur
spike
protein
known
time
write
far
author
awar
time
sar
cov
spke
protein
structur
known
circa
homolog
sar
spike
protein
genbank
entri
bat
coronaviru
spike
protein
enter
januari
present
studi
homolog
sar
protein
three
dimension
structur
known
least
access
present
author
also
protein
model
bind
studi
hamper
region
around
site
sarscov
partli
disord
conform
requir
longer
period
studi
human
protein
respons
bind
cleavag
also
complet
clear
though
sever
laboratori
may
clearer
pictur
recent
notion
kind
sar
doubtless
promot
avenu
enquiri
cours
number
studi
concern
human
protein
bind
activ
sarscov
alreadi
time
ago
carri
sever
group
eg
ref
angiotensin
convert
enzym
type
respons
bind
sar
type
ii
transmembran
serin
proteas
appear
respons
activ
cleavag
sarscov
sever
structur
known
protein
data
bank
proteas
gener
kind
includ
entri
hepsin
sever
group
examin
specif
cleavag
specif
analysi
six
type
ii
transmembran
serin
proteas
eg
ref
note
obviou
sequenc
relationship
krsfiedllfnkv
type
ii
serin
proteas
angiotensinogen
angiotensin
variou
substrat
enzym
potenti
interest
may
act
aeaalrklleva
use
explor
activ
site
dock
deduc
manner
design
studi
cleavag
specif
analysi
six
type
ii
transmembran
serin
proteas
use
pic
proteom
identif
proteas
cleavag
site
proteomederiv
peptid
librari
signific
relationship
except
hint
revers
charg
eg
ed
rk
krsfiedllfnkv
aeaalrklleva
peptid
number
agent
block
bind
activ
studi
appear
number
differ
mechan
eg
ref
conform
flexibl
epitop
retroinverso
agonist
propos
also
challeng
flexibl
advantag
pharmaceut
action
vivo
although
increas
entropi
cost
bind
like
adjust
fit
bind
site
even
fit
differ
relev
site
manner
locksmith
skeleton
key
sens
peptidomimet
toler
design
choic
intend
fit
perfect
molecul
adjust
comput
howev
increas
wellknown
problem
call
multipl
minima
problem
damino
acid
residu
dextro
gnflldeifsrkspkspc
distinct
conform
possibl
even
one
consid
conform
state
per
amino
acid
residu
gross
underestim
would
distinct
conform
energyminim
subject
molecular
dynam
consid
free
peptid
alon
often
separ
signific
energi
barrier
obtain
deeper
insight
studi
perform
explor
intrins
conform
prefer
krsfiedllfnkv
dextro
gnflldeifsrkspk
spc
ie
receptor
present
stabl
top
hundr
might
identifi
softwar
use
krunch
suit
illustr
appendix
ref
use
model
pseudoatom
artifici
interact
center
repres
first
shell
water
approach
describ
detail
section
one
molecular
mechan
use
energi
minim
capabl
explor
multipl
minima
boost
variou
algorithm
help
explor
conform
energi
space
whole
howev
mani
conform
compar
low
energi
found
simpli
support
idea
candid
peptid
section
conform
flexibl
start
extend
structur
essenti
e
residu
specif
backbon
dihedr
angl
prefer
overal
secondari
structur
reason
accord
predict
made
protein
made
use
gor
iv
segment
pskrsfiedllfnkvt
damino
acid
sequenc
revers
consist
mirror
imag
conform
revers
sequenc
effect
simpli
mean
conform
mirror
imag
damino
acid
peptid
case
appear
departur
local
deep
minima
notabl
edllfnk
tend
occasion
adopt
angl
around
characterist
return
extend
conform
preliminari
bind
studi
similar
barr
e
et
al
use
spike
protein
retorinverso
peptid
suggest
variou
mode
bind
vari
circa
kcalmol
number
taken
serious
rel
valu
meaning
scale
adjust
correct
factor
establish
previou
higher
grade
molecular
dynam
calcul
event
calcul
includ
potenti
strong
entropi
contribut
conform
ideal
overal
solutesolv
system
system
use
explor
host
cell
bind
activ
cell
entri
ie
bind
model
chosen
basi
inhibitor
common
similar
sar
bind
activ
entri
b
ligand
includ
inhibitor
enzym
medic
import
discuss
model
system
initi
part
simpli
practic
set
relev
studi
suggest
certain
relationship
action
small
molecul
reveal
autosurf
describ
choic
undoubtedli
like
concern
involv
human
enzym
unlik
involv
entri
nonetheless
prove
insight
consid
rel
recent
histori
pharmacolog
ignor
atom
detail
protein
ligand
propos
bioactiv
small
molecul
bind
norm
pharmacologist
use
evid
hunch
deduc
pharmacophor
ie
abstract
descript
molecular
featur
necessari
molecular
recognit
ligand
protein
ration
strategi
use
present
studi
one
make
model
bind
site
draw
use
conclus
use
actual
experiment
structur
protein
known
bind
similar
ligand
like
give
realist
insight
justif
pharmacophor
target
choic
clear
featur
refut
choic
present
author
call
target
refut
principl
least
worthi
first
choic
straw
man
ie
conjectur
critic
debat
preliminari
pharmacophor
model
might
later
refin
ad
except
condit
descript
choic
target
protein
model
govern
sever
consider
discuss
mostli
reveal
autosurf
approach
motiv
problem
conform
flexibl
peptid
ligand
investig
author
collabor
focus
rigid
steroidlik
scaffold
bind
group
also
molecul
roughli
resembl
steroidlik
piec
one
studi
use
lead
known
inhibitor
steroidlik
plant
deriv
call
carbenoxolon
list
piec
relat
molecul
screen
bind
least
superfici
resembl
emodin
compound
came
attent
import
present
studi
autosurf
found
emodin
alreadi
shown
inhibitor
sarscov
entri
see
fig
thu
analog
put
antagonist
entri
even
importantli
found
sever
studi
eg
ref
shown
emodin
carbenoxelon
see
fig
molecul
similar
inhibit
dehydrogenas
type
rodent
human
experiment
structur
enzym
avail
bound
carbenoxolon
protein
data
bank
entri
structur
also
includ
nadp
cofactor
seri
anthraquinon
compound
shown
inhibit
steroidprocess
enzym
dehydrogenas
type
human
mice
emodin
identifi
potent
select
krunch
method
molecular
model
use
commerci
avail
although
molecular
dynam
dock
part
suit
whole
essenti
standard
avail
version
past
sometim
replac
standard
avail
version
core
approach
less
usual
charact
predominantli
concern
conform
space
phase
space
base
molecular
dynam
dimens
simul
time
core
approach
descend
earlier
develop
protein
peptid
model
simul
newtonian
dynam
rather
appli
energi
minim
techniqu
particular
call
simplex
method
depend
continu
deriv
method
navig
potenti
energi
surfac
pit
multipl
small
energi
minima
approach
extend
pursuit
identifi
global
minimum
minima
globex
method
look
trend
deep
minima
larger
scale
final
embellish
varieti
techniqu
explor
conform
space
effici
roughli
speak
howev
histori
simul
give
similar
impress
molecular
dynam
albeit
run
high
temperatur
period
cool
anneal
initi
bind
studi
use
dehydrogenas
type
receptor
activ
viru
similar
use
ref
earli
altern
choic
bind
protein
model
includ
growth
hormon
secretagogu
receptor
type
genpept
access
evid
literatur
action
anthraquinon
emoghrelin
deriv
indanthron
amongst
other
featur
emodin
initi
suspicion
sequenc
segment
growth
hormon
receptor
might
contribut
bind
featur
relat
current
peptid
interest
none
altern
ultim
seen
persuas
steroid
dehydrogenas
choic
preliminari
studi
present
project
also
suggest
possibl
similar
bind
activ
site
steroid
dehydrogenas
peptid
epitop
propos
b
retroinverso
peptidomimet
c
compound
carbenoxelon
alreadi
studi
somewhat
intens
author
collabor
emodin
see
although
initi
result
bind
peptid
kcalmol
initi
seem
promis
emodin
carbenoxelon
bound
significantli
lower
discuss
peptid
bind
differ
show
multipl
similar
energi
bind
mode
although
dehydrogenas
differ
model
system
directli
relat
interest
observ
regard
emodin
bind
might
extens
relev
simul
manner
consist
target
refut
principl
use
softwar
describ
ref
appendix
ref
initi
studi
compris
simpli
superimpos
smaller
analogu
steroid
core
carbenoxolon
use
posit
analog
keton
atom
steroidlik
framework
carbenoxelon
serin
side
chain
oxygen
atom
pivot
remov
carbenoxolon
initi
local
minim
energi
new
enzymeligand
system
conform
chang
enzym
replac
emodin
depend
critic
choic
dialectr
constant
valu
less
gave
less
rm
practic
one
convent
rule
thumb
aromat
ring
contribut
kcalmol
go
aqueou
nonpolar
environ
although
carbenoxolon
steroidlik
expect
fit
hydrophob
pocket
ampl
evid
often
hydrogen
bond
occur
steroid
receptor
present
system
howev
despit
signific
differ
conform
adjust
protein
accommod
two
ligand
neg
electrostat
tension
region
keton
group
due
close
approach
serin
side
chain
oxygen
atom
phenol
oxygen
tyr
also
oxygen
nadp
cofactor
electrostat
tension
would
seem
provid
evid
choic
target
protein
accord
target
refut
principl
howev
recal
catalysi
consid
includ
serin
proteas
type
mechan
proteolysi
believ
requir
activ
viru
entri
also
cut
lysin
residu
follow
arginin
carri
posit
charg
sidechain
consequ
relev
dismiss
also
cours
bind
favor
overal
inde
despit
electrostat
tension
bind
energi
kcalmol
adjust
previou
high
grade
calcul
section
obtain
emodin
carbenoxelon
respect
seem
reason
indic
signific
bind
howev
valu
taken
predict
experiment
bind
free
energi
comment
rel
valu
entropi
still
appli
overal
solutesolv
system
even
though
ligand
much
rigid
compound
contain
one
steroidlik
ring
azanaphthalen
show
bind
similarli
bind
simul
method
other
bind
show
multipl
bind
mode
recal
lamino
sequenc
gpskrsfiedllfnkvtlac
propos
bepitop
synthes
l
amino
acid
attach
carrier
purpos
rais
antibodi
diagnost
potenti
vaccin
letter
case
might
requir
addit
peptid
tepitop
immun
system
memori
might
come
anywher
protein
even
elsewher
viru
perhap
agent
molecular
adjuv
known
consider
state
art
although
vaccin
base
synthet
approach
still
rel
disfavor
human
use
despit
increas
use
veterinari
medicin
reason
may
part
histor
difficulti
synthes
longer
peptid
without
side
reaction
accumul
error
insert
amino
acid
whole
protein
synthes
even
damino
acid
case
fold
mirror
imag
nativ
form
increasingli
held
synthet
peptid
vaccin
approach
sometim
effect
tradit
vaccin
method
steadili
increas
popular
main
problem
overcom
vaccin
diagnost
design
analog
issu
therapeut
peptidomimet
seem
mani
pathogen
b
epitop
antigen
determin
antibodi
product
discontinu
section
sequenc
use
one
typic
deliv
poor
result
howev
sinc
section
link
chemic
run
connect
amino
acid
glycin
strictli
speak
layer
design
especi
three
dimension
structur
protein
known
immedi
futur
probabl
still
requir
signific
amount
experiment
trial
error
refin
design
certainli
facilit
one
first
obtain
activ
studi
differ
continu
epitop
ultim
link
peptid
togeth
recal
also
damino
acid
sequenc
gnflldeifsrksrkspc
propos
synthesi
damino
acid
act
antagonist
viral
entri
reason
retroinverso
approach
lpeptid
would
suscept
proteolysi
varieti
human
protein
silico
comput
simul
make
possibl
use
lpeptid
dpeptid
standard
molecular
mechan
dynam
emul
catalysi
would
take
remark
sophist
fast
quantum
mechan
calcul
lpeptid
result
may
also
help
design
process
vivo
dpeptid
would
much
longer
halflif
work
either
human
protein
requir
bind
often
believ
angiotensin
convert
enzym
type
respons
bind
sarscov
lung
cell
inhibitor
prevent
proteolysi
requir
activ
spike
protein
time
write
type
ii
transmembran
serin
proteas
favor
respons
activ
cleavag
author
favor
inhibit
proteolysi
peptid
correct
least
know
form
sar
spike
protein
experi
lysin
k
termin
segment
pkspc
correspond
proteolyt
cleavag
point
segment
pskr
must
suffici
degre
bind
inhibitor
activ
ie
catalyt
site
mani
competit
inhibitor
work
bind
revers
common
view
even
point
view
author
defin
competit
inhibit
way
howev
main
bind
recognit
site
may
thing
also
mechan
enzym
may
bind
either
inhibitor
substrat
never
time
alloster
interact
allow
competit
noncompetit
uncompetit
inhibit
peptid
bind
anoth
site
could
act
enhanc
enzym
activ
act
agonist
viral
entri
certainli
practic
advantag
focus
proteas
laboratori
inhibit
initi
test
without
use
viru
viru
protein
strictli
speak
rel
strength
bind
viru
peptid
matter
gener
seen
seriou
obstacl
practic
origin
propos
retroinverso
compound
suggest
prolin
p
substitut
arginin
r
end
section
rkspc
modif
somewhat
statu
hunch
best
weak
rule
sens
section
demot
present
paper
would
seem
hardli
worthi
mention
except
prolin
play
recurr
high
profil
role
histori
design
peptidomimet
modif
might
still
worth
consid
bind
recommend
retroinverso
peptid
neglig
weak
briefli
variou
idea
use
presid
studi
involv
consid
advantag
prolin
residu
lack
nh
group
retroinverso
peptid
suspect
involv
unfavor
nhhn
interact
differ
flexibl
critic
point
peptid
bond
cistran
isomer
replac
extens
rotat
also
concern
residu
l
specif
proteolysi
racem
l
still
occur
point
damino
acid
residu
sequenc
howev
former
stereochem
consider
appli
steroid
process
enzym
bind
inhibitor
model
necessarili
lung
proteas
even
consid
former
model
also
object
discuss
beyond
current
scope
argument
amongst
pharmaceut
scientist
especi
earli
stage
studi
bioinformat
combin
hunch
experienc
pharmaceut
synthet
chemistri
often
provid
reliabl
guidelin
exampl
comput
ligandprotein
bind
simul
hamper
complex
conform
space
least
decad
investig
bioinformat
consid
import
earli
step
certainli
view
present
author
collabor
main
role
project
describ
present
paper
initi
describ
bioinformat
strategi
rather
bind
studi
work
case
discuss
briefli
shortli
explor
autom
compar
task
autom
protein
model
drug
design
present
author
involv
eg
ref
seem
clear
rel
simpl
seri
bioinformat
step
readili
autom
main
task
kind
work
detect
sequenc
conserv
surfac
protein
across
viral
potenti
bacteri
parasit
group
organ
strain
like
expos
exterior
predict
coil
c
help
discuss
text
b
program
set
rule
detail
choic
amino
acid
residu
sequenc
chang
section
gave
set
rule
present
studi
readili
automat
rule
essenti
one
stood
test
time
appear
logic
justifi
design
synthet
vaccin
autom
alreadi
extens
implement
predict
softwar
mani
worker
essenti
tool
predict
rulesofthumb
particularli
sens
may
work
case
may
need
adjust
trialanderror
basi
also
weak
rule
evid
gener
applic
question
could
work
special
case
rule
origin
specif
section
consider
lack
gener
prolin
discuss
section
current
comput
chemistri
protein
model
bind
simul
popular
tool
practic
howev
must
use
caution
complex
conform
space
relat
strong
entrop
contribut
includ
cours
surround
solvent
probabl
main
reason
ibm
high
perform
comput
blue
gene
origin
develop
premis
worker
includ
present
author
might
abl
predict
least
three
dimension
structur
smaller
protein
fold
simul
last
year
comput
time
succeed
howev
achiev
mani
insight
protein
model
discuss
ref
went
applic
includ
drug
design
base
read
us
patent
time
evolv
design
dock
molecular
dynam
simul
scale
adjust
factor
use
molecular
mechan
krunch
approach
section
also
depend
sophist
high
grade
simul
sourc
error
includ
also
typic
includ
neglect
quantum
mechan
contribut
neglect
quantiz
vibrat
model
base
primarili
atom
repres
center
interact
essenti
mean
limit
potenti
function
turn
may
larg
mean
neglect
chang
interact
interact
center
environ
electr
field
preliminari
conform
bind
studi
carri
present
studi
one
may
conclud
approach
propos
peptid
challeng
involv
mani
degre
freedom
conform
gener
sens
simul
method
need
enhanc
method
assess
protein
proteinligand
interact
model
eg
ref
heurist
overcom
multipl
minimum
problem
eg
ref
far
particular
cite
approach
provid
quick
solut
standard
person
comput
pharmaceut
reason
move
toward
smaller
nonpeptid
analogu
may
best
direct
probabl
best
await
detail
experiment
structur
viral
human
protein
involv
activ
interact
electrostat
tension
appli
choic
pharmacophor
may
make
optim
model
system
comput
experi
incident
observ
provid
use
clue
insight
earlier
studi
relat
compound
includ
carbenoxelon
convert
keton
group
thioketon
deriv
compound
studi
appear
enhanc
bind
first
relax
electrostat
tension
despit
increas
increas
van
der
waal
repuls
subsequ
appreci
stronger
partial
charg
requir
thioketon
sulfur
benzen
ring
chemic
strongli
electroneg
carri
closer
full
electron
unit
charg
c
bond
length
thiobenzophenon
thioformaldehyd
due
steric
interact
phenyl
group
coplanar
dihedr
angl
sccc
nonetheless
bind
energi
emodin
thioketon
fell
kcalmol
investig
howev
thioketon
group
optim
choic
explor
might
well
caus
oligomer
practic
studi
like
support
idea
replac
correspond
keton
group
multipl
ring
substructur
steroidlik
structur
might
reason
explor
pursuit
potent
analogu
cours
appropri
pharmacophor
could
one
hydrogen
bond
requir
met
model
mani
principl
similar
epitop
select
appli
therapeut
pepidomimet
design
least
rel
simpl
step
propos
retroinverso
candid
worthi
earli
strategi
ground
show
suggest
want
activ
one
might
well
consid
unfortun
great
deal
comput
medicin
chemistri
laboratori
synthesi
test
done
find
later
use
retroinverso
approach
would
creat
success
first
candid
outset
limit
approach
one
must
awar
coincident
match
truli
signific
unless
one
see
protein
compar
essenti
function
famili
order
similar
section
preserv
correspond
make
sens
light
background
biolog
knowledg
even
arm
knowledg
one
must
wari
make
big
jump
curiou
exampl
present
studi
follow
author
experi
simpl
revers
peptid
sequenc
ie
use
lamino
acid
sometim
requir
activ
interest
also
perform
blast
search
revers
sequenc
one
closest
match
close
match
revers
sequenc
sequenc
bacteri
enzym
interconvert
l
alanin
bifunct
udpnacetylmuramoyltripeptid
dalanyldalanin
ligas
also
known
alanin
racemas
specif
nflldeifsrkspk
find
similar
section
nfllneefsvikspk
racemas
id
interest
coincid
yet
stand
investig
primarili
amino
acid
residu
varieti
part
racemas
appear
interact
itssubstr
sequenc
significantli
preserv
larg
number
relat
divers
racemas
ongo
fight
infecti
diseas
acceler
progress
identif
relev
peptid
appropri
design
smaller
drug
molecul
base
appli
eg
ref
progress
provid
mani
addit
tool
strategi
could
use
case
one
might
find
repurpos
exist
drug
herbal
extract
suspect
genuin
efficaci
may
help
challeng
kind
stop
press
note
time
studi
seem
plausibl
angiotensin
convert
enzym
inhibitor
could
job
petidomimet
base
certain
molecular
similar
recent
studi
highlight
customari
ace
inhibitor
like
counterproduct
effect
although
ace
inhibitor
might
well
work
use
like
concentr
requir
may
excess
effect
blood
pressur
aerosol
prepar
might
use
howev
much
research
need
howev
peptidomimet
base
motif
perhap
also
deliv
aerosol
could
perhap
specif
less
side
effect
design
discoveri
rigid
molecul
similar
van
der
waal
electrostat
surfac
would
tradit
pharmaceut
choic
fiction
movi
contagion
herbal
plant
supplement
claim
cure
fiction
viral
infect
play
role
villain
compar
establish
mainstream
method
vaccin
drug
design
howev
villaini
herbal
origin
rather
fraudul
experi
movi
claim
support
efficaci
exampl
medicin
plant
often
found
ace
inhibitor
action
eg
ref
mani
compound
studi
work
referenc
section
plant
extract
deriv
analogu
carbenoxelon
deriv
product
licoric
plant
alreadi
proven
clinic
trial
market
antiinflammatori
treatment
stomach
ulcer
steroidlik
emodin
isol
rhubarb
buckthorn
japanes
knotwe
produc
mani
speci
fungi
preliminari
comparison
retroinverso
peptid
carbenoxelon
emodin
could
cours
emerg
coincident
similar
kind
revers
sequenc
use
retroinverso
petidomimet
sequenc
alanin
racemeas
discuss
futur
think
web
beyond
current
world
wide
web
emerg
semant
web
remain
import
goal
facilit
respons
old
emerg
diseas
seem
clear
nonetheless
rapid
access
emerg
literatur
bioinformat
tool
avail
internet
guid
human
research
time
yet
remain
import
weapon
battl
virus
pathogen
quel
tool
similar
approach
help
paper
provid
commun
promot
gener
applic
think
professor
paul
dirac
human
anim
medicin
accord
charter
dirac
foundat
emphas
advantag
simplic
basic
form
hyperbol
dirac
net
encourag
use
propos
least
principl
associ
quel
univers
exchang
languag
medicin
basi
standard
interoper
mathemat
engin
principl
use
amongst
mani
other
integr
way
algorithm
intern
architectur
featur
bioinginecom
distribut
system
develop
ingin
inc
cleveland
ohio
mine
infer
big
data
commerci
purpos
barri
robson
bsc
hon
phd
dsc
professor
emeritu
medicin
five
year
chief
scientif
offic
ibm
global
healthcar
pharmaceut
life
scienc
prior
six
year
strateg
advisor
ibm
global
research
headquart
j
watson
research
centr
year
held
prestigi
titl
ibm
distinguish
engin
accord
barri
two
page
biographi
written
journalist
brendan
horton
natur
barri
pioneer
bioinformat
protein
model
computeraid
drug
design
recipi
sever
honour
includ
asklepio
award
outstand
vision
scienc
technolog
futur
health
technolog
congress
mit
help
start
sever
compani
divis
uk
usa
barri
continu
ceo
dirac
foundat
uk
distinguish
scientist
admin
univers
wisconsinstout
depart
mathemat
statist
comput
scienc
also
cofound
ingin
inc
virginia
usa
medic
ai
compani
continu
work
collabor
ibm
also
univers
research
director
professor
ebm
biostatist
epidemiolog
st
matthew
univers
school
medicin
help
establish
earlier
day
cayman
island
barri
also
hold
harvardmaci
diploma
busi
medic
educ
immedi
prior
join
ibm
hire
princip
scientist
mdl
inform
system
california
help
put
togeth
technolog
multimillion
sale
bioinformat
system
hold
compani
form
craig
venter
celera
genom
produc
first
draft
human
genom
prior
cso
gryphon
scienc
later
gryphon
pharmaceut
south
san
francisco
california
bionanotechnolog
ultrastructur
chemistri
startup
larg
held
acquir
smithklin
beecham
move
us
barri
scientif
founder
proteu
intern
plc
uk
design
lead
develop
prometheu
expert
system
underli
global
expert
system
bioinformat
simul
languag
drug
vaccin
diagnost
discoveri
sold
equival
million
pharmaceut
industri
proteu
also
led
team
use
expert
system
invent
patent
sever
diagnost
vaccin
includ
mad
cow
diseas
diagnost
subsequ
market
worldwid
abbott
scientif
public
natur
scienc
j
mol
biol
biochem
j
includ
patent
two
book
engin
hippocr
dawn
medicin
medic
pharmaceut
informat
robson
baek
wiley
page
introduct
protein
protein
engin
b
robson
j
garnier
garnier
elsevi
page
contribut
sever
report
govern
eu
us
denmark
includ
panel
nation
innov
initi
innov
america
publish
council
competit
washington
dc
whitepap
presid
unit
state
also
advisor
relat
major
scientif
computeraid
drug
design
collabor
network
peter
feinstein
consult
work
us
scientist
russian
scienc
citi
arzama
